Saxagliptin hydrochloride

Definition: Saxagliptin, sold under the brand name Onglyza, is an oral hypoglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on the marketing of the drug. In April 2016, the U.S. FDA added a warning about increased risk of heart failure. source: Wikipedia

ID

734452007

ID date

20 Apr 2018

Previous ID

15937911000001100

Name

Saxagliptin hydrochloride